ORAL ADMINISTRATION OF PEPTIDE THERAPEUTICS, SUCH AS GLP-1
Applicants:
- Novo Nordisk (Denmark) [NORA names: Novo Nordisk; Private Research; Denmark; Europe, EU; Nordic; OECD]
Abstract
Disclosed herein are compositions comprising a GLP-1 peptide and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid for use as a medicament by oral administration.
Patent Family Records (1)
ORAL ADMINISTRATION OF PEPTIDE THERAPEUTICS, SUCH AS GLP-1
NOVO NORDISK AS, Novo Nordisk (Denmark) BÆKDAL TINE AGGERHOLM, WELCH JOHANNA EMMA CARITA, HAUGAARD SINE PFEIFFER, (...more)
2024, WO-2024110614-A1